Back

A patient with HF and LVEF > 40%: neurohumoral modulators.

27 August 2022 (11:15 - 11:30)
Organised by:
Congress Presentation Part of: How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40% Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

3 More presentations in this session

Presentation thumbnail
A patient with HF and LVEF > 40%: SGLT2 inhibitors.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
A patient with HF and LVEF > 40%: exercise training.
Professor E. Van Craenenbroeck (Edegem, BE)
Slides Video
Presentation thumbnail
Putting it all together: what to do for a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%.
Professor M. Jessup (Dallas, US)
Slides Video

Access the full session

Session thumbnail
How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Session
Making best use of the new drugs: ARNI and SGLT2 inhibitors across the spectrum of heart failure
26 August 2022
thumbnail
Congress Presentation
A closer look at heart failure drugs: particular benefits and problems.
28 August 2022
thumbnail
Congress Session
New perspectives for the treatment of chronic heart failure
1 September 2024
thumbnail
Congress Session
Biomarkers to guide the treatment of heart failure: where are we going?
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources